Pharma14 is glad to announce the addition of Israel to its global medicine database. 

Israel’s pharmaceutical market value will increase from around $1.9 billion in 2013 to $2.34 billion by 2020,driven by medical technology advances, high R&D expenditure and a robust economy. Total imports of pharmaceutical products from the United States to Israel in 2017 accounted for $280 million.